The growth in the Peripheral Bone Densitometers Market is majorly driven by the increasing prevalence of osteoporosis and the rising geriatric population. However, factors such as the high cost of bone densitometers and low awareness are expected to hinder the growth of this market.
Download a PDF Brochure @ www.marketsandmarkets.com/pdfdownloadNew.asp?id=15369222
The osteoporosis & osteopenia diagnosis segment is expected to grow at the highest CAGR
On the basis of application, the Bone Densitometers Market has been segmented into osteoporosis & osteopenia diagnosis, body composition measurement, rheumatoid arthritis diagnosis, cystic fibrosis diagnosis, and chronic kidney disease diagnosis. The osteoporosis & osteopenia diagnosis segment is projected to grow at the highest CAGR during the forecast period. This can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.
Request a Sample Pages @ www.marketsandmarkets.com/requestsampleNew.asp?id=15369222
The hospitals & specialty clinics segment accounted for the largest share of the bone densitometers market in 2018
Based on end user, the Peripheral Bone Densitometers Market is segmented into hospitals & specialty clinics, diagnostic & imaging centers, and other end users. In 2018, hospitals & specialty clinics accounted for the largest share of the market, and this trend is expected to continue during the forecast period. The majority of bone density scans are performed in hospitals owing to the higher preference of patients for hospital-based treatment monitoring for diseases such as cystic fibrosis, chronic kidney diseases, and osteoporosis.
The Asia Pacific is expected to grow at the highest rate in the Peripheral Bone Densitometers Market in 2018
The Peripheral Bone Densitometers Market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Asian countries (particularly China and India) are expected to offer significant growth opportunities for market players in the forecast period, primarily due to the rising geriatric population, increasing incidence of osteoporosis, increasing healthcare expenditure, and the growing number of hospitals and clinics.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Key Market Players:
GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.P.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), Eurotec Systems S.r.l (Italy), Ampall Co., Ltd. (South Korea), L’acn L’accessorio Nucleare S.R.L (Italy), Shenzen XRAY Electric Co., Ltd. (China), YOZMA BMTech Co., Ltd. (South Korea), Nanoomtech Co., Ltd. (South Korea), Osteosys Corporation (South Korea), FURUNO Electric Co., Ltd. (Japan), Xianyang Kanrota Digital Ultrasound System, Co., Ltd. (China), XinGaoYi Co., Ltd. (China), Anjue Medical Equipment (China), Oscare Medical Oy (Finland), Medilink (France), CyberLogic, Inc. (US), Nanjing Kejin Industrial Co., Ltd. (China), and Trivitron Healthcare (India).